{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:53:58Z","timestamp":1781070838726,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1245\/s10434-024-16838-w","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:44:31Z","timestamp":1739119471000},"page":"3098-3105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer"],"prefix":"10.1245","volume":"32","author":[{"given":"Neal","family":"Bhutiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Nancy","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Messick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Skibber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0762-3457","authenticated-orcid":false,"given":"Abhineet","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,9]]},"reference":[{"key":"16838_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fonc.2019.00318","volume":"9","author":"C Gani","year":"2019","unstructured":"Gani C, Gani N, Zschaeck S, et al. Organ preservation in rectal cancer: the patients\u2019 perspective. Front Oncol. 2019;9:318. https:\/\/doi.org\/10.3389\/fonc.2019.00318.","journal-title":"Front Oncol"},{"issue":"8","key":"16838_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/dcr.0000000000001029","volume":"61","author":"AM Couwenberg","year":"2018","unstructured":"Couwenberg AM, Intven MPW, Burbach JPM, Emaus MJ, van Grevenstein WMU, Verkooijen HM. Utility scores and preferences for surgical and organ-sparing approaches for treatment of intermediate and high-risk rectal cancer. Dis Colon Rectum. 2018;61(8):911\u20139. https:\/\/doi.org\/10.1097\/dcr.0000000000001029.","journal-title":"Dis Colon Rectum"},{"issue":"23","key":"16838_CR3","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/jco.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546\u201356. https:\/\/doi.org\/10.1200\/jco.22.00032.","journal-title":"J Clin Oncol."},{"issue":"10139","key":"16838_CR4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/s0140-6736(18)31078-x","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537\u201345. https:\/\/doi.org\/10.1016\/s0140-6736(18)31078-x.","journal-title":"Lancet."},{"issue":"1","key":"16838_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/dcr.0000000000002930","volume":"67","author":"GP S\u00e3o Juli\u00e3o","year":"2024","unstructured":"S\u00e3o Juli\u00e3o GP, Fern\u00e1ndez LM, Vailati BB, et al. Local regrowth and the risk of distant metastases among patients undergoing watch-and-wait for rectal cancer: What is the best control group? Multicenter retrospective study. Dis Colon Rectum. 2024;67(1):73\u201381. https:\/\/doi.org\/10.1097\/dcr.0000000000002930.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"16838_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/dcr.0000000000002494","volume":"66","author":"LM Fernandez","year":"2023","unstructured":"Fernandez LM, S\u00e3o Juli\u00e3o GP, Renehan AG, et al. The risk of distant metastases in patients with clinical complete response managed by watch and wait after neoadjuvant therapy for rectal cancer: the influence of local regrowth in the international watch and wait database. Dis Colon Rectum. 2023;66(1):41\u20139. https:\/\/doi.org\/10.1097\/dcr.0000000000002494.","journal-title":"Dis Colon Rectum"},{"key":"16838_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.23.00219","volume":"8","author":"N Bhutiani","year":"2024","unstructured":"Bhutiani N, Yousef MM, Yousef A, et al. An automated, high-throughput platform to generate a high-reliability, comprehensive rectal cancer database. JCO Clin Cancer Inform. 2024;8:e2300219.","journal-title":"JCO Clin Cancer Inform."},{"key":"16838_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1186\/s12885-015-1632-z","volume":"15","author":"JJ Smith","year":"2015","unstructured":"Smith JJ, Chow OS, Gollub MJ, et al. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC cancer. 2015;15:767. https:\/\/doi.org\/10.1186\/s12885-015-1632-z.","journal-title":"BMC cancer."},{"issue":"12","key":"16838_CR9","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","volume":"22","author":"M Maas","year":"2015","unstructured":"Maas M, Lambregts DM, Nelemans PJ, et al. Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol. 2015;22(12):3873\u201380. https:\/\/doi.org\/10.1245\/s10434-015-4687-9.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"16838_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol. 2024;42(5):500\u20136. https:\/\/doi.org\/10.1200\/JCO.23.01208.","journal-title":"J Clin Oncol."},{"issue":"6","key":"16838_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/bjs\/znad051","volume":"110","author":"SJD Temmink","year":"2023","unstructured":"Temmink SJD, Peeters KCMJ, Bahadoer RR, et al. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD). Br J Surg. 2023;110(6):676\u201384. https:\/\/doi.org\/10.1093\/bjs\/znad051.","journal-title":"Br J Surg"},{"issue":"3","key":"16838_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/dcr.0000000000002197","volume":"65","author":"GC Cotti","year":"2022","unstructured":"Cotti GC, Pandini RV, Braghiroli OFM, et al. Outcomes of patients with local regrowth after nonoperative management of rectal cancer after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2022;65(3):333\u20139. https:\/\/doi.org\/10.1097\/dcr.0000000000002197.","journal-title":"Dis Colon Rectum."},{"issue":"7","key":"16838_CR13","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1245\/s10434-017-5841-3","volume":"24","author":"T Sammour","year":"2017","unstructured":"Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative management or \u201cwatch and wait\u201d for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal. Ann Surg Oncol. 2017;24(7):1904\u201315. https:\/\/doi.org\/10.1245\/s10434-017-5841-3.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"16838_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/codi.16032","volume":"24","author":"A Chandramohan","year":"2022","unstructured":"Chandramohan A, Mittal R, Dsouza R, et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis. 2022;24(4):428\u201338. https:\/\/doi.org\/10.1111\/codi.16032.","journal-title":"Colorectal Dis."},{"issue":"2","key":"16838_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijrobp.2021.05.136","volume":"111","author":"JJ Tan","year":"2021","unstructured":"Tan JJ, Carten RV, Babiker A, Abulafi M, Lord AC, Brown G. Prognostic importance of MRI-detected extramural venous invasion in rectal cancer: a literature review and systematic meta-analysis. Int J Radiat Oncol Biol Phys. 2021;111(2):385\u201394. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.05.136.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"16838_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50903","volume":"7","author":"HM Thompson","year":"2024","unstructured":"Thompson HM, Omer DM, Lin S, et al. Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial. JAMA Netw Open. 2024;7(1):e2350903. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50903.","journal-title":"JAMA Netw Open."},{"issue":"12","key":"16838_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamasurg.2021.4566","volume":"156","author":"S Deidda","year":"2021","unstructured":"Deidda S, Elmore U, Rosati R, et al. Association of delayed surgery with oncologic long-term outcomes in patients with locally advanced rectal cancer not responding to preoperative chemoradiation. JAMA Surg. 2021;156(12):1141\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2021.4566.","journal-title":"JAMA Surg"},{"issue":"5","key":"16838_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41416-020-0941-4","volume":"123","author":"S Murahashi","year":"2020","unstructured":"Murahashi S, Akiyoshi T, Sano T, et al. Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence. Br J Cancer. 2020;123(5):803\u201310. https:\/\/doi.org\/10.1038\/s41416-020-0941-4.","journal-title":"Br J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16838-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:22:51Z","timestamp":1744096971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16838-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["16838"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16838-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,9]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Oliver Peacock is a Proctor for Device Technology\/Intuitive. Abhineet Uppal has received honorarium from Bayer Pharmaceuticals, 9\/2022. Neal Bhutiani, Kentaro Ochiai, Y. Nancy You, Brian K. Bednarski, Craig Messick, John M. Skibber, Michael G. White, George J. Chang, and Tsuyoshi Konishi have no conflicts of interest to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}